FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2947584447> ?p ?o ?g. }

• W2947584447 abstract "e18137 Background: HCC is the 2nd most common cause of cancer death in the world. We investigate if increased access to various treatment modalities improved outcomes in a public hospital setting. Access to procedural-based treatments improved with development of an in hospital interventional radiology program that resulted from increased public hospital funding starting in 2013 at University Medical Center in New Orleans (UMC). Methods: A retrospective chart review was conducted to analyze 124 patients (pts) diagnosed with HCC from 2013 to 2018 at UMC to determine effect of treatment modality on outcome. Comparative analysis and Fisher’s exact test was performed using a previous study analyzing a similar population (n = 107) from 2007-2013. Results: Pts with HCC treated with transarterial chemoembolization (TACE) had an overall survival (OS) of 82.55% and 54.84% at 1 and 3 years (yr). Pts not treated with TACE had OS of 60.69% and 38.49% at 1 and 3 yr. OS in the 2007-2013 cohort at 1 year was 29%. Progression free survival (PFS) in pts treated with TACE was 52.99% and 22.66% at 1 and 3 yr. PFS in patients not treated with TACE was 58.36% and 50.28% at 1 and 3 yr. Treatment with Sorafenib (S) with or without TACE had OS of 75.84% and 48.43% at 1 and 3 yr. Pts not receiving S had an OS of 69.17% and 48.47% at 1 and 3 yr. PFS was 37.27% and 10.57% in pts treated with S at 1 and 3 yr. PFS for pts not treated with S was 67.00% and 47.02% over 1 and 3 yr. There were 140 total IR procedures which averages to 1.13 IR procedures per pt. Compared to 2007-2013 cohort, more HCC pts had TACE (10% to 56%, p < 0.001) and received S (18% to 39%,p < 0.001). Conclusions: Although PFS was not better for those pts treated with TACE (p value = 0.218), OS was statistically better with TACE (p value = 0.003). Radiologic response rates do not appear to correlate with OS benefit, perhaps due to TACE effect on image interpretation. PFS was decreased in pts treated with S (p value = < 0.0001), possibly due to its use in pts who have progressed despite TACE. The 2013-2018 cohort has superior OS compared to the 2007-2013 cohort at 1 yr. Increased access to procedural- based, locoregional therapy and S positively impacts patient outcomes." @default.
• W2947584447 created "2019-06-07" @default.
• W2947584447 creator A5021501573 @default.
• W2947584447 creator A5081162450 @default.
• W2947584447 creator A5081355045 @default.
• W2947584447 creator A5091635207 @default.
• W2947584447 date "2019-05-20" @default.
• W2947584447 modified "2023-09-27" @default.
• W2947584447 title "Improved hepatocellular carcinoma (HCC) outcomes in a public hospital setting with increased access to procedural-based therapy." @default.
• W2947584447 doi "https://doi.org/10.1200/jco.2019.37.15_suppl.e18137" @default.
• W2947584447 hasPublicationYear "2019" @default.
• W2947584447 type Work @default.
• W2947584447 sameAs 2947584447 @default.
• W2947584447 citedByCount "0" @default.
• W2947584447 crossrefType "journal-article" @default.
• W2947584447 hasAuthorship W2947584447A5021501573 @default.
• W2947584447 hasAuthorship W2947584447A5081162450 @default.
• W2947584447 hasAuthorship W2947584447A5081355045 @default.
• W2947584447 hasAuthorship W2947584447A5091635207 @default.
• W2947584447 hasConcept C126322002 @default.
• W2947584447 hasConcept C143998085 @default.
• W2947584447 hasConcept C144024400 @default.
• W2947584447 hasConcept C2776231280 @default.
• W2947584447 hasConcept C2778019345 @default.
• W2947584447 hasConcept C2779903281 @default.
• W2947584447 hasConcept C2993652001 @default.
• W2947584447 hasConcept C36289849 @default.
• W2947584447 hasConcept C512399662 @default.
• W2947584447 hasConcept C71924100 @default.
• W2947584447 hasConceptScore W2947584447C126322002 @default.
• W2947584447 hasConceptScore W2947584447C143998085 @default.
• W2947584447 hasConceptScore W2947584447C144024400 @default.
• W2947584447 hasConceptScore W2947584447C2776231280 @default.
• W2947584447 hasConceptScore W2947584447C2778019345 @default.
• W2947584447 hasConceptScore W2947584447C2779903281 @default.
• W2947584447 hasConceptScore W2947584447C2993652001 @default.
• W2947584447 hasConceptScore W2947584447C36289849 @default.
• W2947584447 hasConceptScore W2947584447C512399662 @default.
• W2947584447 hasConceptScore W2947584447C71924100 @default.
• W2947584447 hasLocation W29475844471 @default.
• W2947584447 hasOpenAccess W2947584447 @default.
• W2947584447 hasPrimaryLocation W29475844471 @default.
• W2947584447 hasRelatedWork W1995611952 @default.
• W2947584447 hasRelatedWork W1997974607 @default.
• W2947584447 hasRelatedWork W2008326059 @default.
• W2947584447 hasRelatedWork W2040505605 @default.
• W2947584447 hasRelatedWork W2086496034 @default.
• W2947584447 hasRelatedWork W2162392094 @default.
• W2947584447 hasRelatedWork W2265481498 @default.
• W2947584447 hasRelatedWork W2433097314 @default.
• W2947584447 hasRelatedWork W2590526397 @default.
• W2947584447 hasRelatedWork W2604879666 @default.
• W2947584447 hasRelatedWork W2611291269 @default.
• W2947584447 hasRelatedWork W2792702414 @default.
• W2947584447 hasRelatedWork W2906329910 @default.
• W2947584447 hasRelatedWork W2978034280 @default.
• W2947584447 hasRelatedWork W3026574785 @default.
• W2947584447 hasRelatedWork W3044432772 @default.
• W2947584447 hasRelatedWork W3133836180 @default.
• W2947584447 hasRelatedWork W3133972402 @default.
• W2947584447 hasRelatedWork W3134400573 @default.
• W2947584447 hasRelatedWork W3137067045 @default.
• W2947584447 isParatext "false" @default.
• W2947584447 isRetracted "false" @default.
• W2947584447 magId "2947584447" @default.
• W2947584447 workType "article" @default.